Richard E. Gilbert

Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children

Kara Nerenberg, Kelly B. Zarnke, Alexander A. C. Leung et al. · Canadian Journal of Cardiology · 2018 · 575 citations

Risk Assessment, Blood Pressure Monitoring, Hypertension +9

Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

Subodh Verma, C. David Mazer, Andrew T. Yan et al. · Circulation · 2019 · 550 citations

Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes.

Mark E. Cooper, Dimitria Vranes, Sherif Youssef et al. · Diabetes · 1999 · 473 citations

Immunology, Renal Inflammation, Receptor Vegfr-2 +21

Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial

Marc A. Pohl, Samuel S. Blumenthal, D Cordonnier et al. · Journal of the American Society of Nephrology · 2005 · 373 citations

Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults

Alexander A. C. Leung, Stella S. Daskalopoulou, Kaberi Dasgupta et al. · Canadian Journal of Cardiology · 2017 · 319 citations

Risk Assessment, Blood Pressure Monitoring, Hypertension +10